Connect with us

Technology

Implantica announces further expansion of RefluxStop™ access in the UK NHS public Hospital Network

Published

on

VADUZ, Liechtenstein, June 19, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that another NHS Trust hospital, the University Hospital Southampton, a leading public teaching hospital in the south of England, is now performing the RefluxStop™ procedure.

General and Clinical Lead for Upper Gastrointestinal Surgery, Consultant Surgeon Mr. Fergus Noble, undertook the RefluxStop™ procedure to treat severe GORD in a 30-year-old female with a hiatus hernia and oesophagitis. 

He says: “The patient is doing well following surgery; she recovered quickly and was eating normally within days.  Her severe symptoms, including vomiting, chest pain, sore throat, reflux, and epigastric pain and discomfort, have all been resolved without the need for ongoing medication.”

“We are delighted to be the first site in the South of England to offer this procedure to patients suffering from this chronic and debilitating condition.” Mr. Noble is planning to perform more cases later this month.

“RefluxStop is potentially revolutionary: The procedure is minimally invasive and restores the body’s natural physiology allowing it to function normally. The current data shows the potential for patients to experience significantly fewer side effects compared to what’s typically associated with other anti-reflux surgery, as it does not encircle the food passageway. It offers some NHS patients a viable treatment option for the first time.”

An estimated 9.5 million people in the UK suffer from GORD today.¹ The introduction of RefluxStop to the UK NHS is estimated to improve quality of life through favourable health outcomes while being cost-effective against other available treatment options.2 With an estimated £760 million in resource implications due to GORD in the UK annually1, in addition to lost productivity from presenteeism (9.5%), and absenteeism (0.4 hr/week/employee)3, implementation of RefluxStop may provide substantial benefit to the UK NHS and the economy as a whole. 

Implantica’s CEO, Dr. Peter Forsell, says: “It is exciting that the RefluxStop™ procedure is now offered at yet another NHS hospital in the UK, the largest single public healthcare system in Europe. This is a substantial milestone and a sincere recognition of the distinguished and unique value of RefluxStop™ therapy that is now being offered to patients with severe GORD. The addition of Southampton significantly expands patient access in the south of UK and this success builds on the momentum we are building in other European markets. We once again welcome Mr. Noble and the University Hospital Southampton to the growing community of surgeons performing the RefluxStop™ therapy.”

Nirwan JS, Hasan SS, Babar ZU, Conway BR, Ghori MU. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep. 2020 Apr 2;10(1):5814. doi: 10.1038/s41598-020-62795-1. PMID: 32242117; PMCID: PMC7118109.

Harper S, Grodzicki L, Mealing S, Gemmill L, Goldsmith PJ, Ahmed AR. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. J Med Econ. 2023 Jan-Dec;26(1):603-613. doi: 10.1080/13696998.2023.2201063. PMID: 37042668.

Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Nuevo J. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes. 2009 Oct 16;7:90. doi: 10.1186/1477-7525-7-90. PMID: 19835583; PMCID: PMC2770561.

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on June 19, 2024, at 08:00 a.m. (CET).

About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

About RefluxStop™
RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It’s unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GORD involve encircling the food passageway to support the lower oesophageal sphincter’s closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.

In contrast, the RefluxStop™ device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower oesophageal sphincter in its original, natural position.

The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.

Newsroom
https://www.implantica.com/media/media-kit

Community
https://ch.linkedin.com/company/implantica
https://www.twitter.com/implantica

Media Contact:
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-announces-further-expansion-of-refluxstop–access-in-the-uk-nhs-public-hospital-network,c4003438

The following files are available for download:

https://mb.cision.com/Main/19732/4003438/2874540.pdf

Implantica announces further expansion of RefluxStopâ„¢ access in the UK NHS public Hospital Network

https://news.cision.com/implantica/i/logo-transparent-1-8,c3312650

logo transparent 1 8

https://news.cision.com/implantica/i/southampton,c3312651

Southampton

https://news.cision.com/implantica/i/reluxstop-product,c3312652

ReluxStop Product

 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-further-expansion-of-refluxstop-access-in-the-uk-nhs-public-hospital-network-302176527.html

Continue Reading

Technology

Can AI care for us? CNN’s Innovate explores the new frontier of tech in the care sector

Published

on

By

HONG KONG, Oct. 29, 2026 /PRNewswire/ — While artificial intelligence continues to dominate global headlines amid fierce debates over the future of human jobs, a quiet revolution is happening in the United States in the homes of 73-year-old Dee Humphrey and Parkinson’s patient Jerry Feldman — where tech innovations could usher in a new model of care for a sector that often suffers from human staff shortages.

In the upcoming episode of Innovate, CNN travels across the United States to profile the breakthrough AI companions and robots that hold the potential of stepping in to help bridge critical gaps in healthcare, companionship, and physical support — exploring whether technology can truly assist without losing essential human connection and judgment.

The show begins in New York State, where senior citizen Dee Humphrey shares her home with ‘ElliQ’, a lamp-like AI companion that chats, plays games and nudges her to exercise or take her medication. Its creator, Intuition Robotics co-founder Dor Skuler, sees it as a way to support an ageing population. Innovate will seek to answer this question: how can a machine offer companionship without replacing human connection?

The program turns next to Cincinnati Children’s Hospital Medical Center, where nurse Desauna Tabor and her colleagues are helping train ‘Rachel’, an AI telephone assistant they say uncovers families’ needs and frees up time at the bedside. For Hippocratic AI co-founder Munjal Shah, whose mother stopped taking medication without anyone following up, the alternative often isn’t a human calling — it’s no call at all. He believes AI can make abundance in caregiving available “for the first time in human history”, provided it knows when to hand over to a person.

Finally, CNN visits Atlanta, where Jerry Feldman, who lives with Parkinson’s, works with Dr Madeleine Hackney to test ‘ZEST-E’, an exercise robot — and helps researchers understand what users actually need. The show also meets Hello Robot CEO Aaron Edsinger, who wants robots to help when human support isn’t available. For Jerry, that means getting medicine or something to eat when he’s alone and movement is difficult.

The world is changing fast, and emerging technologies are driving the transformation. Artificial intelligence, blockchain, and IoT are just a few of the game-changing innovations that are shaping our lives and revolutionizing how we work, learn, live, and entertain ourselves. CNN’s Innovate series tells the stories behind business ideas, technological developments, and entrepreneurial breakthroughs reshaping our world. Told through a compelling multiplatform approach, Innovate will engage audiences with stories of innovative thinkers from all walks of life who are shaping a better, smarter future for all.

Innovate trailers: https://bit.ly/4iakogb
Innovate images: https://bit.ly/4zNEm6u

Airtimes for Innovate: 
Saturday, 31st October at 6:30pm HKT
Sunday, 1st November at 9:30am and 4:30pm HKT
Monday, 2nd November at 2:30am HKT

About CNN International

CNN’s portfolio of news and information services is available in seven different languages across all major TV, digital and mobile platforms, reaching more than 379 million households around the globe. CNN International is the number one international TV news channel according to all major media surveys across Europe, the Middle East and Africa, the Asia Pacific region, and Latin America and has a US presence that includes CNNgo. CNN Digital is a leading network for online news, mobile news and social media. CNN is at the forefront of digital innovation and continues to invest heavily in expanding its digital global footprint, with a suite of award-winning digital properties and a range of strategic content partnerships, commercialised through a strong data-driven understanding of audience behaviours. CNN has won multiple prestigious awards around the world for its journalism. Around 1,000 hours of long-form series, documentaries and specials are produced every year by CNNI’s non-news programming division. CNN has 36 editorial offices and more than 1,100 affiliates worldwide through CNN Newsource. CNN International is a division of the Skydance Corporation.   

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/can-ai-care-for-us-cnns-innovate-explores-the-new-frontier-of-tech-in-the-care-sector-302923161.html

SOURCE CNN International

Continue Reading

Technology

Can AI care for us? CNN’s Innovate explores the new frontier of tech in the care sector

Published

on

By

HONG KONG, Oct. 29, 2026 /PRNewswire/ — While artificial intelligence continues to dominate global headlines amid fierce debates over the future of human jobs, a quiet revolution is happening in the United States in the homes of 73-year-old Dee Humphrey and Parkinson’s patient Jerry Feldman — where tech innovations could usher in a new model of care for a sector that often suffers from human staff shortages.

In the upcoming episode of Innovate, CNN travels across the United States to profile the breakthrough AI companions and robots that hold the potential of stepping in to help bridge critical gaps in healthcare, companionship, and physical support — exploring whether technology can truly assist without losing essential human connection and judgment.

The show begins in New York State, where senior citizen Dee Humphrey shares her home with ‘ElliQ’, a lamp-like AI companion that chats, plays games and nudges her to exercise or take her medication. Its creator, Intuition Robotics co-founder Dor Skuler, sees it as a way to support an ageing population. Innovate will seek to answer this question: how can a machine offer companionship without replacing human connection?

The program turns next to Cincinnati Children’s Hospital Medical Center, where nurse Desauna Tabor and her colleagues are helping train ‘Rachel’, an AI telephone assistant they say uncovers families’ needs and frees up time at the bedside. For Hippocratic AI co-founder Munjal Shah, whose mother stopped taking medication without anyone following up, the alternative often isn’t a human calling — it’s no call at all. He believes AI can make abundance in caregiving available “for the first time in human history”, provided it knows when to hand over to a person.

Finally, CNN visits Atlanta, where Jerry Feldman, who lives with Parkinson’s, works with Dr Madeleine Hackney to test ‘ZEST-E’, an exercise robot — and helps researchers understand what users actually need. The show also meets Hello Robot CEO Aaron Edsinger, who wants robots to help when human support isn’t available. For Jerry, that means getting medicine or something to eat when he’s alone and movement is difficult.

The world is changing fast, and emerging technologies are driving the transformation. Artificial intelligence, blockchain, and IoT are just a few of the game-changing innovations that are shaping our lives and revolutionizing how we work, learn, live, and entertain ourselves. CNN’s Innovate series tells the stories behind business ideas, technological developments, and entrepreneurial breakthroughs reshaping our world. Told through a compelling multiplatform approach, Innovate will engage audiences with stories of innovative thinkers from all walks of life who are shaping a better, smarter future for all.

Innovate trailers: https://bit.ly/4iakogb
Innovate images: https://bit.ly/4zNEm6u

Airtimes for Innovate: 
Saturday, 31st October at 6:30pm HKT
Sunday, 1st November at 9:30am and 4:30pm HKT
Monday, 2nd November at 2:30am HKT

About CNN International

CNN’s portfolio of news and information services is available in seven different languages across all major TV, digital and mobile platforms, reaching more than 379 million households around the globe. CNN International is the number one international TV news channel according to all major media surveys across Europe, the Middle East and Africa, the Asia Pacific region, and Latin America and has a US presence that includes CNNgo. CNN Digital is a leading network for online news, mobile news and social media. CNN is at the forefront of digital innovation and continues to invest heavily in expanding its digital global footprint, with a suite of award-winning digital properties and a range of strategic content partnerships, commercialised through a strong data-driven understanding of audience behaviours. CNN has won multiple prestigious awards around the world for its journalism. Around 1,000 hours of long-form series, documentaries and specials are produced every year by CNNI’s non-news programming division. CNN has 36 editorial offices and more than 1,100 affiliates worldwide through CNN Newsource. CNN International is a division of the Skydance Corporation.   

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/can-ai-care-for-us-cnns-innovate-explores-the-new-frontier-of-tech-in-the-care-sector-302923161.html

SOURCE CNN International

Continue Reading

Technology

xTool Officially Launches X1: An Upgradable Multi-Laser Platform Engineered for Speed, Versatility, and Business Growth

Published

on

By

Moving beyond traditional wattage wars, xTool’s new flagship platform combines high-speed Galvo with large-format Gantry motion, introducing modular LaserSwap™ technology and Automated Creation System™ (ACS™) to redefine desktop digital fabrication.

MOUNTAIN VIEW, Calif., Oct. 29, 2026 /PRNewswire/ — xTool, a global pioneer in digital fabrication solutions, today announced the official worldwide availability and immediate shipping of the xTool X1, the industry’s first future-proof, continuously upgradable smart flagship laser engraver and cutter. Built to bridge the gap between industrial-grade capabilities and desktop accessibility, the xTool X1 solves hundreds of complex engineering challenges to deliver an all-in-one productivity engine for small businesses, 3D printing enthusiasts, and woodworking makers alike.  

Beyond the Wattage Wars: A Leap in Motion Architecture

For years, the desktop laser industry has been locked in a race toward higher wattage without addressing fundamental workflow constraints. The xTool X1 fundamentally shifts this narrative by proving that the next frontier of laser technology lies in motion architecture rather than simple power upgrades.  

By seamlessly integrating a high-speed Flying-Galvo system with a large-format Dragon-Gantry workspace, the X1 eliminates the age-old compromise between engraving speed and working area. Driving two distinct motion systems through a synchronized 4-axis linkage, the X1 achieves ultra-fast galvo processing without sacrificing the broad spatial range required for large-scale production.  

To guarantee rock-solid precision under extreme operational speeds, xTool engineered the X1 using a 4,000-ton industrial UniCast high-pressure die-cast aluminum frame. This rigid structural foundation, combined with advanced software feathering algorithms, completely eliminates micro-vibrations and visual seam boundaries, ensuring flawless optical alignment across both flat and 3D surfaces.  

“Users see a seamless ‘Place & Go’ experience on the surface, but under the hood, the X1 solves hundreds of optical, algorithmic, and mechanical variables,” said Jessie Liu, President of xTool. “The future of desktop fabrication is not about replacing machines every time your business expands; it’s about system-level upgrades. X1’s true strength isn’t just a single laser beam—it’s the ability to make multiple laser sources work together in perfect harmony.”  

LaserSwap™ and Automated ACS™: True System-Level Upgradability

At the heart of the X1 platform is the proprietary LaserSwap™ modular ecosystem. Starting with a high-capacity 55W CO2 module or a hybrid 55W CO2 / 20W Diode setup, users can effortlessly expand their capabilities through quick-connect “backpack” laser modules. The system supports optional 30W Fiber, 60W MOPA, and 5W UV lasers, enabling users to perform deep metal engraving, vibrant color marking, and delicate non-thermal surface processing without buying standalone machines.

Complementing its multi-laser capability, the X1 introduces the Automated Creation System™ (ACS™) to put laser processing on autopilot. Delivering an unprecedented “Place & Go” workflow, ACS™ combines an integrated triple-camera system that pinpoints material positioning with sub-millimeter precision, and an AutoLift Base that automatically adjusts bed height. This hands-off automation eliminates guesswork, manual setup, and tedious focusing, drastically elevating creator productivity.

Unlocking New Workflows Across Communities

The xTool X1 is specifically designed to overcome material limits and unlock new commercial opportunities across diverse creative sectors:  

The Ultimate Companion for 3D Printing: While 3D printers excel at complex volumetric geometries, they struggle with structural paneling and fast production. The X1 serves as the perfect companion machine, cutting rigid structural components in wood, acrylic, or leather, while applying high-resolution UV or laser marking directly onto PLA and resin models.  A High-ROI Growth Engine for SMBs: Designed for home decor studios, signage makers, and custom gift shops, the X1 operates as an efficient “one-person factory”. Its rapid batch-engraving speeds and multi-material versatility drastically reduce production lead times, allowing small businesses to expand their product SKUs and achieve rapid return on investment.  Empowering Woodworking & DIY Makers: For artisanal woodworkers, the X1 seamlessly merges natural materials with precise metal accents. From customized home and garden decor to intricate woodworking projects, the platform handles mixed-material crafting with effortless consistency.

Technical Difficulty: Laser Innovation vs. 3D Printing

Developing the X1 required overcoming engineering hurdles that far surpass conventional digital tools. While 3D printing primarily manages material extrusion and thermal dynamics, multi-laser hybrid platforms demand extreme optical precision, real-time light path alignment, multi-axis motion synchronization, and complex blending algorithms. The X1’s success establishes xTool’s undeniable technical leadership in mastering these industrial-grade challenges for the desktop market.  

Pricing and Availability

The xTool X1 is available for purchase starting today on the official xTool online store, featuring limited-time launch pricing across multiple configurations:  

X1 Single CO2 (55W CO2): $3,399X1 CO2 + Diode Galvo (55W CO2 + 20W Diode Galvo Module): $3,999X1 CO2 + Diode Galvo + Fiber (Includes 30W Fiber Laser Source): $5,799X1 CO2 + Diode Galvo + UV (Includes 5W UV Laser Source): $6,499X1 CO2 + Diode Galvo + MOPA (Includes 60W MOPA Laser Source): $6,679

To learn more about the xTool X1, explore detailed technical specifications, or place an order, please visit: xtool.com.

About xTool

xTool is a global premium consumer-tech brand dedicated to empowering digital-to-physical creation. As the world’s largest and fastest-growing laser engraver innovator, xTool provides a comprehensive ecosystem of laser-based personal creative tools, material printers, user-friendly software, accessories, and consumables. Through these innovations, xTool empowers creators to turn imagination into meaningful creations that deliver emotional fulfillment, commercial success, and personal achievement. Discover more at xtool.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtool-officially-launches-x1-an-upgradable-multi-laser-platform-engineered-for-speed-versatility-and-business-growth-302923167.html

SOURCE xTool

Continue Reading

Trending